Fortrea adds William Sharbaugh to board of directors

Fortrea (NASDAQ: FTRE) announced the appointment of William Sharbaugh to its board of directors. The Durham, North Carolina-based contract research organization said Sharbaugh brings more than three decades of pharmaceutical industry experience in finance, operations, manufacturing and quality.

Sharbaugh currently serves as chairman of the board at Ora LLC, an ophthalmic research organization, and sits on the board of Launch Therapeutics Inc., a late-stage pharmaceutical development company. He previously worked as an operating partner for Vistria Group from September 2022 to July 2025.

His executive experience includes serving as chief operating officer at PPD Inc., a contract research organization, from 2007 to 2021, and as vice president of Global Development Operations at Bristol-Myers Squibb from 2001 to 2007. He also spent 10 years at Merck & Co. in various roles including clinical supply operations, sales and manufacturing.

"He is a highly respected leader, who understands our stakeholders and what it takes to deliver high-quality drug development globally," said Anshul Thakral, CEO of Fortrea.

Sharbaugh holds degrees from the U.S. Military Academy at West Point, the University of Pennsylvania's Wharton School, Temple University School of Pharmacy, and Boston University. He served as an officer in the U.S. Army in a Patriot missile battalion.

The information is based on a company press release.

You May Also Be Interested In

• Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
• Soluna names ex-Microsoft executive as chief development officer
• 22nd Century Group names Katherine Rouse-Bailey as VP of Marketing